Abstract
Background: In cystic fibrosis (CF), loss of CF transmembrane conductance regulator (CFTR)-dependent bicarbonate secretion precipitates the accumulation of viscous mucus in the lumen of respiratory and gastrointestinal epithelial tissues. We investigated whether the combination of elexacaftor (ELX), ivacaftor (IVA) and tezacaftor (TEZ), apart from its well-documented effect on chloride transport, also restores Phe508del-CFTR-mediated bicarbonate transport. Methods: Epithelial monolayers were cultured from intestinal and biliary (cholangiocyte) organoids of homozygous Phe508del-CFTR patients and controls. Transcriptome sequencing was performed, and bicarbonate and chloride transport were assessed in the presence or absence of ELX/IVA/TEZ, using the intestinal current measurement technique. Results: ELX/IVA/TEZ markedly enhanced bicarbonate and chloride transport across intestinal epithelium. In biliary epithelium, it failed to enhance CFTR-mediated bicarbonate transport but effectively rescued CFTR-mediated chloride transport, known to be requisite for bicarbonate secretion through the chloride-bicarbonate exchanger AE2 (SLC4A2), which was highly expressed by cholangiocytes. Biliary but not intestinal epithelial cells expressed an alternative anion channel, anoctamin-1/TMEM16A (ANO1), and secreted bicarbonate and chloride upon purinergic receptor stimulation. Conclusions: ELX/IVA/TEZ has the potential to restore both chloride and bicarbonate secretion across CF intestinal and biliary epithelia and may counter luminal hyper-acidification in these tissues.
Original language | English |
---|---|
Pages (from-to) | 537-543 |
Number of pages | 7 |
Journal | Journal of Cystic Fibrosis |
Volume | 21 |
Issue number | 3 |
DOIs | |
Publication status | Published - May 2022 |
Bibliographical note
Funding Information:This study was funded by the Cystic Fibrosis Foundation ( CFF-USA DEJONG16G0 ), the Fondazione Ricerca Fibrosi Cistica ( FFC#3/2016 ), the Dutch Cystic Fibrosis Foundation ( NCFS HIT-CF2 ) and the Dutch Digestive Disease Foundation ( MLDS-Diagnostiek D16–26 ).
Publisher Copyright:
© 2021 The Author(s)